BIO vs TECH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

BIO

49.7
AI Score
VS
TECH Wins

TECH

59.8
AI Score

Investment Advisor Scores

BIO

50score
Recommendation
HOLD

TECH

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIO TECH Winner
Revenue 893.85M 1.24B BIO
Net Income 127.24M -155.70M TECH
Gross Margin 65.7% 52.7% TECH
Net Margin 14.2% -12.5% TECH
Operating Income 177.61M 106.70M TECH
ROE 6.1% -2.2% TECH
ROA 5.0% -1.5% TECH
Total Assets 2.55B 10.25B BIO
Cash 209.82M 517.00M BIO
Current Ratio 4.49 3.14 TECH
Free Cash Flow 176.29M 144.80M TECH

Relative Price Performance (Last 90 Days)

BIO 1M: -5.0% · 3M: +13.9% TECH 1M: +0.1% · 3M: +1.2%

Current Technical Phase

BIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $360.50

TECH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.0 · Price: $72.64

Fundamentals Snapshot

Metric BIO TECH
Market Cap — —
Forward P/E 37.0 42.7
Trailing P/E 44.9 62.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.5% 0.7%
Operating Margin 0.1% 0.3%
EPS 7.89 1.16
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, TECH is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.